Format

Send to

Choose Destination
See comment in PubMed Commons below
Phytochemistry. 2013 Jan;85:153-60. doi: 10.1016/j.phytochem.2012.08.014. Epub 2012 Sep 24.

Biphenyl-type neolignans from Magnolia officinalis and their anti-inflammatory activities.

Author information

  • 1Chung-Jen College of Nursing, Health Sciences and Management, Chiayi 600, Taiwan.

Abstract

Reactive oxygen species (ROS) and granule proteases produced by human neutrophils contribute to the pathogenesis of inflammatory diseases. The MeOH extract of the stem bark of Magnolia officinalis showed potent inhibitory effects on superoxide anion generation and elastase release by human neutrophils in response to formyl-L-methionyl-L-leucyl-L-phenylalanine/cytochalasin B (fMLP/CB). Five biphenyl-type neolignan derivatives, 5-allyl-5'-(1″-hydroxyallyloxy)biphenyl-2,2'-diol, 5,5'-diallyl-2'-(allyloxy)biphenyl-2-ol, 5,5'-diallyl-2'-(3-methylbut-2-enyloxy)biphenyl-2-ol, (E)-5-allyl-3'-(prop-1-enyl)biphenyl-2,4'-diol, and 4-allyl-2-(2'-methylbenzofuran-5'-yl)phenol, have been isolated from the stem bark of M. officinalis, together with 12 known compounds. Several exhibited inhibition (IC₅₀) values ≤10.7 μM) of superoxide anion generation by human neutrophils in response to fMLP/CB. Others inhibited fMLP/CB-induced elastase release with IC₅₀) values ≤8.76 μM.

PMID:
23017219
DOI:
10.1016/j.phytochem.2012.08.014
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center